The surprisingly positive treatment outcomes using Rigvir virotherapy for late stages cancer patients were recently published. The patients of melanoma stage IV M1c, small cell lung cancer stage IIIA ...

(Banff, Canada – March 14, 2005) An international medical conference here heard that an Australian developed anti-cancer therapy based on the use of a common cold virus to control cancer cell growth ...

The immune system has evolved to protect the body from potential threats, including bacterial diseases such as plague, cholera, diphtheria, and Lyme disease, and viral pathogens, including influenza, ...

A multi-institutional team of Chinese microbiologists and pharmacologists has developed a novel way to fight cancerous tumors. Called ONCOTECH, it combines oncolytic virotherapy and adoptive T cell ...

Pancreatic cancer is one of the most aggressive types of malignancies. In this regard, pancreas adenocarcinomas account for the majority of all pancreas cancers and have a dismal 5-year survival rate ...

The experimental oncolytic adenovirus telomelysin (OBP-301) in combination with radiotherapy was safe and showed early clinical efficacy in vulnerable patients with esophageal cancer, according to ...

Simultaneous Durvalumab and Platinum-Based Chemoradiotherapy in Unresectable Stage III Non–Small Cell Lung Cancer: The Phase III PACIFIC-2 Study The following represents disclosure information ...

The study, from investigators at the University of Alabama at Birmingham and Nationwide Children’s Hospital, builds on previous trials of G207. The current study further examined findings from an ...

Article reviewed by Grant McFadden, PhD from Arizona State University and Kalivir Immunotherapeutics. Stay up to date on the latest science with Brush Up Summaries. Researchers are pioneering ...